Table 1

Table.  Drugs for Cervical Cancer

 

 

Product

 

Class

 

Target

 

Clinical Stage

 

Manufacturer

 

MEDI-517

 

Vaccine

 

Immune system

 

Phase II

 

MedImmune

RSR13

(Efaproxiral)

 

Small molecule

Sensitize hypoxic areas of tumors

 

Phase II

 

Allos

 

TA-HPV

 

Vaccine

 

Immune system

 

Phase II

 

Xenova